Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9

H Tarrahimofrad, S Rahimnahal, J Zamani… - Scientific Reports, 2021 - nature.com
A new strain of Influenza A Virus (IAV), so-called" H7N9 Avian Influenza", is the first strain of
this virus in which a human is infected by transmitting the N9 of influenza virus. Although …

Human neutralizing antibodies target a conserved lateral patch on H7N9 hemagglutinin head

M Jia, H Zhao, NC Morano, H Lu, YM Lui, H Du… - Nature …, 2024 - nature.com
Avian influenza A virus H7N9 causes severe human infections with> 30% fatality. Currently,
there is no H7N9-specific prevention or treatment for humans. Here, from a 2013 H7N9 …

Host genes and influenza pathogenesis in humans: an emerging paradigm

KKW To, J Zhou, JFW Chan, KY Yuen - Current opinion in virology, 2015 - Elsevier
Highlights•Host genes play an important role in the pathogenesis of influenza virus
infection.•High-throughput technologies accelerate the discovery of susceptibility …

Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting …

KKW To, KY Mok, ASF Chan… - Journal of General …, 2016 - microbiologyresearch.org
Immunomodulators have been shown to improve the outcome of severe pneumonia. We
have previously shown that mycophenolic acid (MPA), an immunomodulator, has antiviral …

Co-stimulation with TLR7 agonist imiquimod and inactivated influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen …

C Li, KKW To, AJX Zhang, ACY Lee, H Zhu… - Frontiers in …, 2018 - frontiersin.org
Current influenza vaccines have relatively low effectiveness, especially against antigenically
drifted strains, the effectiveness is even lower in the elderly and immunosuppressed …

Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study

K Rungrojcharoenkit, P Sunintaboon, D Ellison… - PLoS …, 2020 - journals.plos.org
Influenza is an infectious respiratory illness caused by influenza viruses. Despite yearly
updates, the efficacy of influenza vaccines is significantly curtailed by the virus antigenic drift …

Avian influenza virus A H7N9 infects multiple mononuclear cell types in peripheral blood and induces dysregulated cytokine responses and apoptosis in infected …

ACY Lee, KKW To, H Zhu, H Chu… - Journal of General …, 2017 - microbiologyresearch.org
Most patients with avian influenza A H7N9 virus (H7N9) infection suffer from severe illness,
accompanied by dysregulated cytokine/chemokine response, delayed viral clearance and …

Peritoneal cells mediate immune responses and cross-protection against influenza A virus

A Gautam, BK Park, TH Kim, M Akauliya, D Kim… - Frontiers in …, 2019 - frontiersin.org
Intraperitoneal inoculation with live influenza A virus confers protection against intranasal
infections in mice and ferrets. However, the responses of peritoneal cells to influenza A virus …

Antibody immunity induced by H7N9 avian influenza vaccines: Evaluation criteria, affecting factors, and implications for rational vaccine design

Z Hu, X Jiao, X Liu - Frontiers in Microbiology, 2017 - frontiersin.org
Severe H7N9 avian influenza virus (AIV) infections in humans have public health authorities
around the world on high alert for the potential development of a human influenza …

Evaluation of the adjuvant effect of imiquimod and CpG ODN 1826 in chimeric DNA vaccine against Japanese encephalitis

X Zang, G Li, J Zhu, X Dong, Y Zhai - International Immunopharmacology, 2024 - Elsevier
Vaccines represent a significant milestone in the history of human medical science and
serve as the primary means for controlling infectious diseases. In recent years, the …